Drug industry weakens US bill about disclosure of giftsBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39598.476250.DB (Published 05 June 2008) Cite this as: BMJ 2008;336:1268
- Bob Burton
The US drug industry has persuaded key Congressional legislators to water down proposed legislation that would require detailed public disclosure of payments and gifts to doctors.
In September 2007 the senators Chuck Grassley and Herb Kohl introduced the Physician Payments Sunshine Act 2007 to counter an estimated $19bn (£9.6bn; €12.3bn) spent a year courting doctors. At the time Mr Grassley told the Senate that “the best disinfectant” to payments to doctors was “sunshine,” which means openness.
Benefits provided to doctors, he said, “can be a simple dinner after work, or they can add …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial